1. |
Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA [J]. Hum Gen Ther, 1999; 10(10)∶1735.
|
2. |
Sharon N, Lis H. Lectins as cell recognition molecules [J]. Science, 1989; 246(4927)∶227.
|
3. |
Han J, Il Yeom Y. Specific gene transfer mediated by galactossylated polyLlysine into hepatoma cells [J]. Int J Pharm, 2000; 202(1-2)∶51.
|
4. |
Park JU, Ishihara T, Kano A, et al. Preparation of dendritic graft coplymer consisting of poly(llysine) and arabinogalactan as a hepatocyte specific DNA carrier [J]. Prep Biochem Biotechnol, 1999;29(4)∶353.
|
5. |
Junbo H, Li Q, Zaide W, et al. Receptormediated interlukin2 gene transfer into human hepatoma cells [J]. Int J Mol Med, 1999; 3(6)∶601.
|
6. |
Takahashi H, Ozturk M, Wilson B, et al. In vivo expression of two novel tumorassociated antigens and their use in immunolocalization of human hepatocellular carcinoma [J]. Hepatology, 1989; 9(4)∶625.
|
7. |
Wilson B, Qzuturk M, Takahashi H, et al. Cell surface changes associated with transformation of human hepatocytes to the malignant phenotype [J]. Proc Natl Acad Sci USA, 1988; 85(9)∶3140.
|
8. |
Mohr L, Schauer JI, Boutin RH, et al. Targeted gene transfer to hepatocellular carcinoma cells in vitro using a novel monoclonal antibodybased gene delivery system [J]. Hepatology, 1999; 29(1)∶82.
|
9. |
Moradpour D, Compagnon B, Wilson BE, et al. Specific targeting of human hepatocellular carcinoma cells by immunoliposomes in vitro [J]. Hepatology, 1995; 22(5)∶1527.
|
10. |
Cotten M, LangleRouault F, Kirlappos H, et al. Transferrinpolycationmediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels [J]. Proc Natl Acad Sci USA, 1990; 87(11)∶4033.
|
11. |
Curiel DT, Agarwal S, Wagner E, et al. Adenovirus enhancement of transferrinpolylysinemediated gne delivery [J]. Proc Natl Acad Sci USA, 1991; 88(19)∶8850.
|
12. |
Moradpour D, Schauer JI, Zurawski VR, et al. Efficient gene transfer into mammalian cells with cholesterylspermidine [J]. Biochem Biophys Res Commun, 1996; 221(1)∶82.
|
13. |
Plank C , Mechtler K, Szoka FC Jr, et al. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery [J]. Hum Gene Ther, 1996; 7(12)∶1437.
|
14. |
Zern MA, Kresina TF. Hepatic drug delivery and gene therapy [J]. Hepatology, 1997; 25(2)∶484.
|
15. |
Somia NV, Zoppe M, Verma IM. Generation of targeted retroviral vectors by using singlechain variable fragment: an approach to in vivo gene delivery [J]. Proc Natl Acad Sci USA,1995; 92(16)∶7570.
|
16. |
Yang Y, Nunes FA, Bernencsi K, et al. Cellular immunity to viral antigens limits E1deleted adenovirus for gene therapy [J]. Proc Natl Acad Sci USA, 1994; 91(10)∶4407.
|
17. |
Engelhardt JF, Ye X, Doranz B, et al.Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver [J]. Proc Natl Acad Sci USA, 1994; 91(13)∶6196.
|
18. |
Ruoslahti E. Alphafetoprotein in cancer and fetal development [J] Adv Cancer Res,1979; 29∶275.
|
19. |
Xu GW, Sun ZT, Forrester K, et al. Tissuespecific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviralmediated transfer of the wildtype P53 gene [J]. Hepatology, 1996; 24(5)∶1264.
|
20. |
Ido A, Nakata K, Kato Y, et al. Gene therapy for hepatoma cells using a retrovirus vector carring herpes simplex virus thymidine kinase gene under the control of human alphafetoprotein gene promoter [J]. Cancer Res, 1995; 55(14)∶3105.
|
21. |
Kanai F, Shiratori Y, Yoshida Y, et al. Gene therapy for alphafetoproteinproducing human hepatoma cells by adenovirusmediated transfer of the herpes simplex virus thymidine kinase gene [J]. Hepatology, 1996; 23(6)∶1359.
|
22. |
Su H, Lu R, Chang JC, et al. Tissuespecific expression of herpes simplex virus thymidine kinase gene delivered by adenoassociated virus inhibits the growth of human hepatocellular carcinoma in athymic mice [J]. Proc Natl Acad Sci USA, 1997; 94(25)∶13891.
|
23. |
Ohguchi S, Nakatsukasa H, Higashi T, et al. Expression of αfetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy [J]. Hepatology, 1998; 27(2)∶599.
|
24. |
Vollmer CM Jr, Eilber FC, Butterfield LH, et al. Alphafetoproteinspecific genetic immunotherapy for hepatocellular carcinoma [J]. Cancer Res,1999; 59(13)∶3064.
|
25. |
Gordon EM, Liu PX, Chen ZH, et al. Inhibition of metastatic tumor growth in nude mice by portal vein infusions of matrixtargeted retroviral vectors bearing a cytocidal cyclin G1 construct [J]. Cancer Res, 2000; 60(13)∶3343.
|